AGP Executive Report
Last update: 7 hours agoHIV Prevention Access: Gilead and PAHO agreed to widen access to twice-yearly lenacapavir (Yeztugo) via PAHO’s regional purchasing system, creating a new pathway for 14 Latin America and Caribbean countries including Peru. Cardiovascular Health: A new American Heart Association report flags that only 1 in 5 Hispanic adults in the U.S. has “ideal” heart health, with high rates of obesity, diabetes, and hypertension driving earlier heart failure. Public Health Alert: The WHO estimates measles cases rose 8% globally versus pre-pandemic 2019 levels, with nearly 11 million expected infections in 2026 and outbreaks reported across the Americas and Europe. Healthcare Innovation: Sidra Medicine will host the PMFG Summit 2026 (Dec 7–9) focused on genomics, AI, and equitable precision medicine. Global Health & Environment: A new analysis links Amazon malaria resurgence to deforestation and land-use governance failures, arguing biomedical tools alone won’t reverse trends.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.